Methylspinazarin

Methylspinazarin is a bacterial naphthoquinone metabolite and a selective COMT inhibitor (IC50 = 0.8 μg/ml) . It has demonstrated in vitro enzyme inhibition and in vivo efficacy, lowering blood pressure in hypertensive rat models at 50 mg/kg, supporting research in neuroscience and cardiovascular pharmacology.